Zylox-Tonbridge Medical Group is a medical device company focused on peripheral vascular and neurovascular interventions. Its portfolio includes more than 40 revascularization products designed to support procedures addressing conditions affecting blood vessels and the brain. Product areas include devices for ischemic and hemorrhagic stroke, vascular access, and peripheral vascular treatment.

The company’s offerings include thrombectomy and clot-retrieval devices, embolization coils, microcatheters, intracranial support catheters, stents, PTA balloon catheters, IVC filters, and vascular closure devices. Its product range also covers venous stent systems and devices used in procedures such as aneurysm treatment and peripheral artery intervention. Zylox-Tonbridge reports product approvals in China and other markets, including the UAE and Indonesia.

Beyond medical devices, the company provides educational resources for patients and healthcare professionals, including procedure overviews, case materials, and explanatory content on vascular and neurovascular treatments. Its website also shares company news, investor information, and environmental, social, and governance reports. Together, these activities reflect a business focused on developing interventional products and supporting knowledge about their clinical applications.